basys.ai vs Cohere Health (2026)
basys.ai and Cohere Health support prior authorization and utilization management by matching clinical records to coverage criteria. basys.ai includes provider preparation tools and payer review software. Cohere sells health plans a platform, delegated clinical review or APIs embedded in existing systems. basys.ai reads records and policies, identifies required documentation and produces reasoning and evidence for review. Its suite extends into concurrent and retrospective review, discharge planning and payment integrity, with cloud or local containerized execution. Provider workflows retain human control. Payer materials describe automated approvals and denials without fully specifying review requirements before adverse decisions. Current accuracy claims do not identify the evaluation population or model version. Cohere's authorization workflow approves requests meeting criteria and sends the rest to clinicians; the company states that AI does not deny care. Plans can use their own teams or delegate specialty review to Cohere's clinicians. Its Humana case describes a deployment since 2021 and operational outcomes, including shorter time to service. Those results are company reported. Nothing sets out its automatic approval thresholds or how errors are handled afterward. basys.ai fits organizations connecting provider request preparation with payer review or requiring local execution. Cohere fits plans choosing between internal clinical operations and delegated utilization management. The distinction is both operational and consequential: basys.ai describes a broader automated decision path, while Cohere routes requests that do not qualify for automatic approval into clinical review.
- Providers need documentation support before submitting requests.
- Local container deployment is required.
- Provider preparation and payer review need related tools.
- Authorization intake must accommodate APIs, portals and fax.
- A plan wants a choice of internal or delegated review.
- AI authorization decisions must be limited to approval or pending review.
- Specialty review needs access to the vendor's clinicians.
- A plan needs authorization tools connected to providers' Epic workflow.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. basys.ai and Cohere Health are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | basys.ai | Cohere Health |
|---|---|---|
| Primary category | RCM & Prior Auth AI | RCM & Prior Auth AI |
| Headquarters | Cambridge, Massachusetts, United States | Boston, Massachusetts |
| Website | basys.ai | coherehealth.com |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
basys.ai develops AI software for prior authorization, utilization management, clinical auditing, and payment integrity. Its platform reads medical records and payer policies, identifies relevant criteria, and produces review outputs with supporting evidence and reasoning. Provider workflows help teams determine what documentation an authorization request needs, while payer workflows support review and communication of coverage decisions.
Source: AI Health Index, October 2026
Clinical intelligence platform sold to health plans for utilization management, payment integrity, appeals, care management, claims operations and quality. Prior authorization requests arrive through Cohere's portal, its APIs or providers' Epic workflow; clinically trained models approve requests that meet criteria in real time (85 percent on the home page, 89 percent at Humana) and pend the rest for a clinician, and the company states its AI does not deny.
Source: AI Health Index, October 2026
Questions buyers ask
How are basys.ai and Cohere Health priced and sold?
For basys.ai, the site offers several review modules and requests contact details for additional whitepapers, but it does not provide a current price schedule. No base fee, usage unit, implementation charge, minimum commitment, or price difference between cloud and local deployment is given.
Cohere sells to health plans in three shapes: a platform the plan's own clinicians run, delegated utilization management run by Cohere's clinicians for named specialties, and APIs embedded into plan systems; payment integrity is sold in house or as a managed audit service. The only economics published are returns, up to 18x for prior authorization and 9x for payment integrity, which say what a plan gets back and not what it pays. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.
How do basys.ai and Cohere Health handle patient data?
In basys.ai's case, the company also describes evidence trails so reviewers can inspect how an output relates to source records.
Cohere's AI principles state the AI never uses explicit patient identifiers, such as names or locations, for care recommendations, and its AI Hub describes a minimum necessary approach that reads only the clinical information a decision needs. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.
Which settings and specialties do basys.ai and Cohere Health cover?
With basys.ai, a March 2026 announcement identifies an ePathUSA partnership supporting the CMS medical record review pilot, with AI intended to assist human reviewers in interpreting documentation and policy requirements.
Cohere names delegated programs in musculoskeletal, cardiovascular, gastrointestinal, sleep, diagnostic imaging and sepsis care, and products across utilization management, payment integrity, appeals, care management, claims operations and quality. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.
What evidence is published for basys.ai and Cohere Health?
For basys.ai, a named pilot or competition selection can show engagement, but the headline metrics have neither reproducible current validation nor independent confirmation.
With Cohere Health, the Humana case study (August 2026) reports a partnership since January 2021 across all 50 states and 5.1 million Medicare Advantage and commercial members, with 95 percent provider digital adoption, an 89 percent auto approval rate, time to service five days shorter, 54 percent fewer nurse review hours and 94 percent of providers satisfied. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers.
basys.ai is based in Cambridge, Massachusetts; Cohere Health is based in Boston. Neither publishes current fees or usage rates. Cohere states URAC and NCQA utilization management accreditation; basys.ai's cited pilots predate the current product.